Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo -: Implications for human breast cancer

被引:188
作者
Engelman, JA
Lee, RJ
Karnezis, A
Bearss, DJ
Webster, M
Siegel, P
Muller, WJ
Windle, JJ
Pestell, RG
Lisanti, MP
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Albert Einstein Canc Ctr, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Albert Einstein Canc Ctr, Bronx, NY 10461 USA
[3] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA
[4] McMaster Univ, Dept Pathol, W Hamilton, ON L8S 4K1, Canada
[5] Canc Therapy & Res Ctr S Texas, San Antonio, TX 78229 USA
关键词
D O I
10.1074/jbc.273.32.20448
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neu (c-erbB2) is a proto-oncogene product that encodes an epidermal growth factor-like receptor tyrosine kinase, Amplification of wild-type c-Neu and mutational activation of Neu (Neu T) have been implicated in oncogenic transformation of cultured fibroblasts and mammary tumorigenesis in vivo. Here, we examine the relationship between Neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Recent studies have suggested that caveolins may function as negative regulators of signal transduction, Our current results show that mutational activation of c-Neu down-regulates caveolin-1 protein expression, but not caveolin-2, in cultured NIH 3T3 and Rat 1 cells. Conversely, recombinant overexpression of caveolin-1 blocks Neu-mediated signal transduction in vice. These results suggest a reciprocal relationship between c-Neu tyrosine kinase activity and caveolin-1 protein expression. We next analyzed a variety of caveolin-1 deletion mutants to map this caveolin-1-dependent inhibitory activity to a given region of the caveolin-1 molecule. Results from this mutational analysis show that this functional in vivo inhibitory activity is contained within caveolin-1 residues 82-95, in accordance with these in vivo studies, a 20-amino acid peptide derived from this region (the caveolin-1 scaffolding domain) was sufficient to inhibit Neu autophosphorylation in an in vitro kinase assay. To further confirm or refute the relevance of our findings in vivo, we next examined the expression levels of caveolin-1 in mammary tumors derived from c-Neu transgenic mice. Our results indicate that dramatic reduction of caveolin-1 expression occurs in mammary tumors derived from c-Neu-expressing transgenic mice and other transgenic mice expressing downstream effecters of Neu-mediated signal transduction, such as Src and Ras, Taken together, our data suggest that a novel form of reciprocal negative regulation exists between c-Neu and caveolin-1.
引用
收藏
页码:20448 / 20455
页数:8
相关论文
共 43 条
[1]   ONCOGENIC ACTIVATION OF THE NEU-ENCODED RECEPTOR PROTEIN BY POINT MUTATION AND DELETION [J].
BARGMANN, CI ;
WEINBERG, RA .
EMBO JOURNAL, 1988, 7 (07) :2043-2052
[2]   STOCHASTIC APPEARANCE OF MAMMARY-TUMORS IN TRANSGENIC MICE CARRYING THE MMTV/C-NEU ONCOGENE [J].
BOUCHARD, L ;
LAMARRE, L ;
TREMBLAY, PJ ;
JOLICOEUR, P .
CELL, 1989, 57 (06) :931-936
[3]   Antigen retrieval in cryostat tissue sections and cultured cells by treatment with sodium dodecyl sulfate (SDS) [J].
Brown, D ;
Lydon, J ;
McLaughin, M ;
StuartTilley, A ;
Tyszkowski, R ;
Alper, S .
HISTOCHEMISTRY AND CELL BIOLOGY, 1996, 105 (04) :261-267
[4]  
CACERES A, 1984, J NEUROSCI, V4, P394
[5]   Interaction of a receptor tyrosine kinase, EGF-R, with caveolins - Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities [J].
Couet, J ;
Sargiacomo, M ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) :30429-30438
[6]   Molecular and cellular biology of caveolae - Paradoxes and plasticities [J].
Couet, J ;
Li, SW ;
Okamoto, T ;
Scherer, PE ;
Lisanti, MP .
TRENDS IN CARDIOVASCULAR MEDICINE, 1997, 7 (04) :103-110
[7]   Identification of peptide and protein ligands for the caveolin-scaffolding domain - Implications for the interaction of caveolin with caveolae-associated proteins [J].
Couet, J ;
Li, SW ;
Okamoto, T ;
Ikezu, T ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (10) :6525-6533
[8]   GROWTH-FACTORS IN BREAST-CANCER [J].
DICKSON, RB ;
LIPPMAN, ME .
ENDOCRINE REVIEWS, 1995, 16 (05) :559-589
[9]   HETERODIMERIZATION AND FUNCTIONAL INTERACTION BETWEEN EGF RECEPTOR FAMILY MEMBERS - A NEW SIGNALING PARADIGM WITH IMPLICATIONS FOR BREAST-CANCER RESEARCH [J].
EARP, HS ;
DAWSON, TL ;
LI, X ;
YU, H .
BREAST CANCER RESEARCH AND TREATMENT, 1995, 35 (01) :115-132
[10]   Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth [J].
Engelman, JA ;
Wykoff, CC ;
Yasuhara, S ;
Song, KS ;
Okamoto, T ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (26) :16374-16381